CoMind is a DeepTech company founded in 2018, headquartered in London, that develops non-invasive brain monitoring solutions using neurophotonics. The firm operates at the intersection of photonics, neurotechnology, and artificial intelligence to address critical needs in clinical neuroscience.
The company's primary product, CoMind One, is a bedside system that provides real-time data on neurophysiological parameters such as cerebral perfusion, autoregulation, and intracranial pressure. Complementing this hardware is CoVision, an AI-powered analytics platform designed to generate predictive clinical insights aimed at improving patient safety and healthcare outcomes.
CoMind's technical work spans neurophotonics, photonics, and the development of AI algorithms for clinical applications. The company was founded by James Dacombe, who was 17 years old at the time of its establishment.
